izpis_h1_title_alt

Application of quality by design principles to the development of oral lyophilizates containing olanzapine
ID Bjelošević Žiberna, Maja (Author), ID Ahlin Grabnar, Pegi (Author)

.pdfPDF - Presentation file, Download (1,83 MB)
MD5: B140DFBBA6F6F019E8400C24BF47A2F5
URLURL - Source URL, Visit https://www.mdpi.com/1999-4923/15/7/1967 This link opens in a new window

Abstract
Oral lyophilizates are intended for application to the oral cavity or for dispersing in water. The purposes of this research were: (i) to set up the quality by design approach in the development of oral lyophilizates for drug incorporation; and (ii) to evaluate the established approach by comparing its outcomes with experimentally obtained results. Within the knowledge space, properties about drugs, excipients, and the lyophilization process were acquired, followed by the determination of critical quality attributes via risk identification. Risks were assessed by failure mode and effective analysis, which recognized critical material attributes, i.e., type, concentration, particle size, solubility of drug and excipients, while as main critical process parameters, cooling rate, shelf temperature, and chamber pressure during drying were pointed out. Additionally, design space was established using the Minitab$^®$ 17 software and valued with an 88.69% coefficient of determination. A detailed comparison between the model and experimental results revealed that the proposed optimal compositions match in the total concentration of excipients (6%, w/w) in the pre-lyophilized liquid formulation, among which mannitol predominates. On the other hand, a discrepancy regarding the presence of gelatin was detected. The conclusion was that the set model represents a suitable onset toward optimization of drug-based oral lyophilizates development, preventing unnecessary investment of time and resources.

Language:English
Keywords:oral lyophilizate, lyophilization, quality by design, disintegration time, Minitab$^®$
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:16 str.
Numbering:Vol. 15, iss. 7, art. 1967
PID:20.500.12556/RUL-148360 This link opens in a new window
UDC:542.47:661.12
ISSN on article:1999-4923
DOI:10.3390/pharmaceutics15071967 This link opens in a new window
COBISS.SI-ID:160781059 This link opens in a new window
Publication date in RUL:18.08.2023
Views:323
Downloads:161
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Pharmaceutics
Shortened title:Pharmaceutics
Publisher:MDPI
ISSN:1999-4923
COBISS.SI-ID:517949977 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:peroralni liofilizati, liofilizacija, kakovost po zasnovi, čas razpadanja, Minitab$^®$, sušenje, farmacevtska tehnologija

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0189
Name:Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih

Funder:ARRS - Slovenian Research Agency
Project number:L1-3160
Name:Razvoj visokokoncentriranih proteinskih formulacij in vrednotenje kinetike absorpcije po subkutani aplikaciji

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back